Neptune Technologies & Bioresources Inc Profit Margin 2009-2019 | NEPT
Current and historical gross margin, operating margin and net profit margin for Neptune Technologies & Bioresources Inc (NEPT) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Neptune Technologies & Bioresources Inc net profit margin as of March 31, 2019 is -94.47%.
| Neptune Technologies & Bioresources Inc Annual Profit Margins |
|---|
| Neptune Technologies & Bioresources Inc Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.368B | $0.018B |
| Neptune Wellness Solutions Inc. operates as a nutrition supplement company. It develops and produces cannabis products, marine oils, seed oils and pet supplements. Neptune Wellness Solutions Inc., formerly known as Neptune Technologies & Bioressources Inc., is headquartered in Laval, Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $147.168B | 28.57 |
| Medtronic (MDT) | Ireland | $131.379B | 18.77 |
| Stryker (SYK) | United States | $73.942B | 26.39 |
| Boston Scientific (BSX) | United States | $56.933B | 27.29 |
| Baxter (BAX) | United States | $41.099B | 25.90 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.191B | 15.54 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $18.938B | 0.00 |
| ResMed (RMD) | United States | $17.154B | 32.78 |
| Canopy Growth (CGC) | Canada | $14.483B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.155B | 48.53 |
| Aurora Cannabis (ACB) | Canada | $7.667B | 75.60 |
| Insulet (PODD) | United States | $7.077B | 515.65 |
| Hill-Rom Holdings (HRC) | United States | $7.035B | 21.33 |
| Perrigo (PRGO) | Ireland | $5.966B | 10.09 |
| Haemonetics (HAE) | United States | $5.845B | 47.71 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $5.309B | 0.00 |
| ICU Medical (ICUI) | United States | $4.968B | 29.64 |
| Hutchison China MediTech (HCM) | China | $3.770B | 0.00 |
| Neogen (NEOG) | United States | $3.289B | 53.47 |
| Agios Pharmaceuticals (AGIO) | United States | $3.048B | 0.00 |
| NuVasive (NUVA) | United States | $2.994B | 24.45 |
| National Vision Holdings (EYE) | United States | $2.410B | 51.35 |
| Quidel (QDEL) | United States | $2.275B | 23.61 |
| Aphria (APHA) | $1.707B | 0.00 | |
| Cardiovascular Systems (CSII) | United States | $1.521B | 873.20 |
| HEXO (HEXO) | $1.425B | 0.00 | |
| Phibro Animal Health (PAHC) | United States | $1.196B | 17.92 |
| AtriCure (ATRC) | United States | $1.169B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.109B | 23.54 |
| Lantheus Holdings (LNTH) | United States | $1.058B | 28.10 |
| OrganiGram Holdings (OGI) | Canada | $0.997B | 0.00 |
| NanoString Technologies (NSTG) | United States | $0.927B | 0.00 |
| PetIQ (PETQ) | United States | $0.900B | 21.86 |
| Quanterix (QTRX) | United States | $0.859B | 0.00 |
| Omeros (OMER) | United States | $0.823B | 0.00 |
| MacroGenics (MGNX) | United States | $0.817B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.748B | 20.99 |
| TG Therapeutics (TGTX) | United States | $0.684B | 0.00 |
| Cerus (CERS) | United States | $0.664B | 0.00 |
| Surmodics (SRDX) | United States | $0.569B | 82.69 |
| OraSure Technologies (OSUR) | United States | $0.540B | 24.89 |
| LeMaitre Vascular (LMAT) | United States | $0.526B | 25.46 |
| Meridian Bioscience (VIVO) | United States | $0.501B | 15.31 |
| Evolus (EOLS) | United States | $0.362B | 0.00 |
| Vapotherm (VAPO) | United States | $0.357B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.335B | 104.71 |
| Utah Medical Products (UTMD) | United States | $0.318B | 21.99 |
| Zynex (ZYXI) | United States | $0.317B | 32.73 |
| Bovie Medical (APYX) | United States | $0.231B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.203B | 0.00 |
| Owens & Minor (OMI) | United States | $0.182B | 3.85 |
| Chimerix (CMRX) | United States | $0.181B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.174B | 0.00 |
| Fonar (FONR) | United States | $0.136B | 7.16 |
| Female Health (VERU) | United States | $0.127B | 0.00 |
| BRAINSWAY LTD (BWAY) | Israel | $0.101B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.100B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.092B | 0.00 |
| Surface Oncology (SURF) | United States | $0.092B | 0.00 |
| United-Guardian (UG) | United States | $0.088B | 19.28 |
| Neurotrope (NTRP) | United States | $0.087B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.061B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.038B | 13.08 |
| Senestech (SNES) | United States | $0.035B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.031B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.030B | 0.00 |
| Insys Therapeutics (INSY) | United States | $0.022B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.021B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.017B | 0.00 |
| Myomo (MYO) | United States | $0.015B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.012B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.007B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.007B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.005B | 3.64 |
